Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On Sernova with Buy Rating, Announces Price Target of C$5 By Benzinga Newsdesk January 5, 5:38 AM EF Hutton analyst Tony Butler initiates coverage on Sernova (TSX:SVA) with a Buy rating and announces Price Target of C$5. TSX:SVA
Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On Compugen with Buy Rating, Announces Price Target of $13 By Benzinga Newsdesk January 5, 5:36 AM EF Hutton analyst Tony Butler initiates coverage on Compugen (NASDAQ:CGEN) with a Buy rating and announces Price Target of $13. CGEN
Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On Fate Therapeutics with Buy Rating, Announces Price Target of $16 By Benzinga Newsdesk January 5, 5:34 AM EF Hutton analyst Tony Butler initiates coverage on Fate Therapeutics (NASDAQ:FATE) with a Buy rating and announces Price Target of $16. FATE
Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On TCR2 Therapeutics with Hold Rating, Announces Price Target of $2 By Benzinga Newsdesk January 5, 5:32 AM EF Hutton analyst Tony Butler initiates coverage on TCR2 Therapeutics (NASDAQ:TCRR) with a Hold rating and announces Price Target of $2. TCRR
Read More 1 minute read Analyst Ratings Initiation News Price Target EF Hutton Initiates Coverage On GT Biopharma with Hold Rating, Announces Price Target of $2 By Benzinga Newsdesk January 5, 5:30 AM EF Hutton analyst Tony Butler initiates coverage on GT Biopharma (NASDAQ:GTBP) with a Hold rating and announces Price Target of $2. GTBP
Read More 1 minute read Analyst Ratings Initiation News Edward Jones Initiates Coverage On GE HealthCare Techs with Hold Rating By Benzinga Newsdesk January 4, 1:57 PM Edward Jones analyst John Boylan initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Hold rating. GEHC
Read More 20 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For January 4, 2023 By Benzinga Insights January 4, 11:01 AM Upgrades UBS upgraded the previous rating for Trane Technologies PLC (NYSE:TT) from Neutral to Buy. For the third… ADSE
Read More 1 minute read Analyst Ratings Initiation News Price Target B of A Securities Reinstates Neutral on Cleveland-Cliffs, Announces $19 Price Target By Benzinga Newsdesk January 4, 9:58 AM B of A Securities analyst Lawson Winder reinstates Cleveland-Cliffs (NYSE:CLF) with a Neutral and announces $19 price target. CLF
Read More 1 minute read Analyst Ratings Initiation News Price Target B of A Securities Reinstates Buy on Nucor, Announces $172 Price Target By Benzinga Newsdesk January 4, 9:55 AM B of A Securities analyst Lawson Winder reinstates Nucor (NYSE:NUE) with a Buy and announces $172 price target. NUE
Read More 1 minute read Analyst Ratings Initiation News William Blair Initiates Coverage On ARS Pharmaceuticals with Outperform Rating By Benzinga Newsdesk January 4, 9:51 AM William Blair analyst Tim Lugo initiates coverage on ARS Pharmaceuticals (NASDAQ:SPRY) with a Outperform rating. SPRY